                         SEQUENCE LISTING

<110>   WuXi Biologics (Shanghai) Co.,Ltd. 
        WuXi Biologics Ireland Limited.
 
<120>  NOVEL ANTI-PD-L1 ANTIBODIES

<130>  IEC196154PCT

<150>  PCT/CN2019/107689
<151>  2019-09-25

<160>  5     

<170>  PatentIn version 3.5

<210>  1
<211>  9
<212>  PRT
<213>  Artificial

<220>
<223>  CDR1

<400>  1

Gly His Phe Ser Asn Leu Ala Val Asn 
1               5                   


<210>  2
<211>  17
<212>  PRT
<213>  Artificial

<220>
<223>  CDR2

<400>  2

Gly Ile Leu Trp Ser Gly Gly Ser Thr Phe Tyr Ala Asp Ser Val Lys 
1               5                   10                  15      


Gly 
    


<210>  3
<211>  3
<212>  PRT
<213>  Artificial

<220>
<223>  CDR3

<400>  3

Gly Thr Asn 
1               


<210>  4
<211>  111
<212>  PRT
<213>  Artificial

<220>
<223>  full length

<400>  4

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly His Phe Ser Asn Leu Ala 
            20                  25                  30          


Val Asn Trp Phe Arg Gln Ala Pro Gly Lys Glu Arg Glu Leu Val Ala 
        35                  40                  45              


Gly Ile Leu Trp Ser Gly Gly Ser Thr Phe Tyr Ala Asp Ser Val Lys 
    50                  55                  60                  


Gly Arg Phe Thr Ile Ser Arg Gly Asn Ala Glu Asn Met Leu Tyr Leu 
65                  70                  75                  80  


Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys Asn 
                85                  90                  95      


Thr Gly Thr Asn Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
            100                 105                 110     


<210>  5
<211>  333
<212>  DNA
<213>  Artificial

<220>
<223>  full length

<400>  5
gaggtgcagc tggtggagtc cggaggcgga ctggtgcagc ctggaggaag cctgagactg       60

agctgcgccg ctagcggcca cttcagcaac ctggccgtga actggttcag gcaggcccct      120

ggcaaggaga gggagctggt ggctggcatc ctgtggagcg gcggaagcac cttctacgcc      180

gacagcgtga agggcaggtt caccatcagc aggggcaacg ccgagaacat gctgtacctg      240

cagatgaact ccctgagggc cgaggacacc gccgtgtact actgcaacac cggcaccaac      300

tggggccagg gcacactcgt gaccgtgagc agc                                   333


